CH679045A5 - - Google Patents

Download PDF

Info

Publication number
CH679045A5
CH679045A5 CH2423/88A CH242388A CH679045A5 CH 679045 A5 CH679045 A5 CH 679045A5 CH 2423/88 A CH2423/88 A CH 2423/88A CH 242388 A CH242388 A CH 242388A CH 679045 A5 CH679045 A5 CH 679045A5
Authority
CH
Switzerland
Prior art keywords
formula
hydrogen
carbon atoms
radical
alkyl
Prior art date
Application number
CH2423/88A
Other languages
German (de)
English (en)
Inventor
Rainer Dr Albert
Wilfried Bauer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH679045A5 publication Critical patent/CH679045A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH2423/88A 1987-06-29 1988-06-24 CH679045A5 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (1)

Publication Number Publication Date
CH679045A5 true CH679045A5 (ja) 1991-12-13

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2423/88A CH679045A5 (ja) 1987-06-29 1988-06-24

Country Status (15)

Country Link
JP (1) JPS6426599A (ja)
KR (1) KR890000520A (ja)
AU (1) AU1840988A (ja)
BE (1) BE1002663A4 (ja)
CH (1) CH679045A5 (ja)
DK (1) DK353788A (ja)
ES (1) ES2010283A6 (ja)
FR (1) FR2617171B1 (ja)
GB (1) GB2206352B (ja)
IL (1) IL86876A0 (ja)
IT (1) IT1221065B (ja)
LU (1) LU87262A1 (ja)
NL (1) NL8801640A (ja)
NZ (1) NZ225188A (ja)
SE (1) SE8802413L (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
ATE291587T1 (de) * 2000-07-31 2005-04-15 Dabur Res Foundation Somatostatin analoge und deren verwendung zur behandlung von krebs
RU2263678C2 (ru) 2001-03-08 2005-11-10 Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд Антагонисты соматостатина
KR20030088494A (ko) * 2001-04-09 2003-11-19 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 소마토스타틴 작용제
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
IT8848133A0 (it) 1988-06-28
JPS6426599A (en) 1989-01-27
DK353788A (da) 1988-12-30
GB8815257D0 (en) 1988-08-03
SE8802413D0 (sv) 1988-06-28
LU87262A1 (fr) 1989-03-08
SE8802413L (sv) 1988-12-30
KR890000520A (ko) 1989-03-15
NZ225188A (en) 1991-04-26
AU1840988A (en) 1989-01-05
FR2617171A1 (fr) 1988-12-30
BE1002663A4 (fr) 1991-04-30
GB2206352A (en) 1989-01-05
DK353788D0 (da) 1988-06-27
GB2206352B (en) 1990-10-31
NL8801640A (nl) 1989-01-16
IL86876A0 (en) 1988-11-30
IT1221065B (it) 1990-06-21
FR2617171B1 (fr) 1994-10-14
ES2010283A6 (es) 1989-11-01

Similar Documents

Publication Publication Date Title
CH682632A5 (de) Mit Zuckerresten modifizierte Peptide.
EP1161452B1 (de) Kovalent verbrückte insulindimere
CH679045A5 (ja)
DE3588095T2 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
CH682152A5 (ja)
DE2321174A1 (de) Nonapeptidamidderivate und verfahren zu ihrer herstellung
DE3207311A1 (de) Neue n-acylpolypeptide und ihre herstellung
DE3333640A1 (de) Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE2705514C3 (de) Nonapeptide und diese enthaltende Arzneimittel
CH626328A5 (en) Process for the preparation of somatostatin analogues
CH615904A5 (en) Process for the preparation of L-leucine-13-motilin
CH649562A5 (de) Derivate des methionin-enzephalins.
DE69425212T2 (de) Dem Motilin ähnliche Polypeptide mit stimulierender Wirkung auf den gastrointestinalen Trakt
EP0589927A1 (de) Geschützter aminosäurebaustein, herstellung und verwendung
DE2112553C3 (de) 1 -alpha-Aminolsobuttersäurecorticotropinpeptide, deren Derivate, Säureadditionssalze und Komplexe sowie Arzneipräparate
DE3328952A1 (de) Neue polypeptide, verfahren zu ihrer herstellung, pharmazeutische praeparate welche sie enthalten, sowie ihre verwendung
DE69511259T2 (de) N-amidino- dermorphin-derivat
DE2739440A1 (de) Pentapeptide und sie enthaltende arzneimittel
DE2804566A1 (de) Polypeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0044451A1 (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
DE2628006C2 (de) Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
EP0095557B1 (de) Polypeptide mit antagonistischen Eigenschaften gegenüber der Substanz P, Verfahren zu ihrer Herstellung, deren Verwendung und Verfahren zum Reinigen von Polypeptiden
DE2602803A1 (de) Octapeptidderivate und verfahren zu deren herstellung
DE3855751T2 (de) Hypoglycemische peptide
DE3820770A1 (de) Polypeptide

Legal Events

Date Code Title Description
PL Patent ceased